Skip to content

Clinical trials

Phase 3 Liver Cirrhosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 3 Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20024
20033
20067
20072
20081
20105
20114
20122
20132
20142
20154
20162
20172
20185
20193
20201
20214
20224
20234
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Unknown status13
Terminated9
Recruiting7
Not yet recruiting4
Withdrawn3
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Sherief Abd-Elsalam4
Beijing Continent Pharmaceutical Co, Ltd.3
Sanofi3
Tanta University3
University of Padova2
Aga Khan University1
Asian Institute of Gastroenterology, India1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis76
Fibrosis14
Hepatitis C10
Ascites9
Hepatitis C, Chronic9
Esophageal and Gastric Varices8
Hypertension, Portal6
Non-alcoholic Fatty Liver Disease5
Carcinoma, Hepatocellular4
Hepatic Encephalopathy4

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.